Doubling Down On Innovation, Recovery


Source: pharmexec.com pharmexec.com

Key Topics in this News Article:

News Snapshot:

Not that long ago, the overall mood in the pharmaceutical and biotechnology industries was somewhat gloomy. The public image of the industry had fallen from being one of the most respected to being characterized as the greedy villain behind high drug prices. Innovation by the large pharma companies had slowed dramatically, even with a slew of innovations focused on speeding up the drug discovery process and on new technologies. The stock market valuations had relentlessly fallen and IPOs of biotech companies were few and far between.Dialing forward to the picture over the last two years or so and the situation...